Lv11
50 积分 2023-05-08 加入
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
4小时前
已完结
Management of Kidney Cancer Relapse to Adjuvant Pembrolizumab: Early Insights and Questions for a Newly Emerging Space
4个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
4个月前
已完结
Nivolumab in patients with metastatic castration-resistant prostate cancer with and without DNA repair defects
4个月前
已完结
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
4个月前
已关闭
Elusive Biomarkers of Sensitivity to Combined PD1/CTLA4 Blockade in Metastatic Castration-Resistant Prostate Cancer
4个月前
已完结
Toxicities of Novel Agents for the Treatment of Advanced Bladder Cancer
5个月前
已完结
[Chinese expert consensus on multidisciplinary discussion of interstitial lung disease]
5个月前
已完结
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
11个月前
已完结
Immune checkpoint inhibitors in colorectal cancer: dream and reality
1年前
已完结
皖公网安备34019202002308
